New hope for deadly Liver-Kidney complication
NCT ID NCT06256432
First seen Apr 16, 2026 · Last updated Apr 16, 2026
Summary
This study is testing whether a drug called ambrisentan can help people with hepatorenal syndrome, a serious kidney complication that occurs in advanced liver cirrhosis and often leads to death. Researchers are comparing ambrisentan against the standard treatment, terlipressin, in 54 hospitalized patients to see which better improves kidney function and survival. Participants who receive ambrisentan will continue taking it at home for up to 60 days after leaving the hospital.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
All India Institute of Medical Sciences
New Delhi, National Capital Territory of Delhi, 110029, India
-
Asian Institute of Gastroenterology (AIG)
Hyderabad, Telangana, 500082, India
-
Aster CMI Hospital
Bangalore, Karnataka, 560092, India
-
Ganesh Shankar Vidyarthi Memorial (GSVM) Medical College
Kanpur, Uttar Pradesh, 208002, India
-
Medanta Multi Super Specialty Hospital
Lucknow, Uttar Pradesh, 226030, India
-
Sir HN Reliance Hospital Foundation
Mumbai, Maharashtra, 400004, India
Conditions
Explore the condition pages connected to this study.